Mutated ras induced PLD1 gene expression through increased Sp1 transcription factor

Area of Science:

• Molecular Biology
• Oncology
• Cell Biology

Background:

• The mechanisms linking oncogene activation to phospholipase D (PLD) activity remain unclear.
• Oncogenic mutations, particularly in Ras, are implicated in various cancers, but their direct effects on PLD regulation need further investigation.

Purpose of the Study:

• To elucidate the role of mutated Ras in regulating phospholipase D1 (PLD1) gene expression.
• To identify the specific transcription factors and regulatory elements involved in Ras-mediated PLD1 activation.

Main Methods:

• Utilized colon cancer cell lines and NIH3T3 cells with mock or mutated Ras transfection.
• Performed 5' promoter analysis, Sp1 inhibition studies (mithramycin A, siRNA), and Sp1 overexpression experiments in Drosophila SL2 cells.
• Employed Electrophoretic Mobility Shift Assay (EMSA) and Chromatin Immunoprecipitation (ChIP) assays.

Main Results:

• Mutated Ras activation correlated with increased PLD1 mRNA and protein levels.
• A specific Sp1-binding site within the PLD1 promoter was identified as crucial for Ras-induced expression.
• Inhibition of Sp1 activity or protein levels reduced PLD1 expression and promoter activity.
• Sp1 protein levels and its binding to the PLD1 promoter motif increased with Ras activation.

Conclusions:

• Sp1 is a critical mediator of Ras-induced PLD1 expression.
• Ras activation enhances PLD1 transcription through increased Sp1 binding to its promoter motif.
• Targeting the Sp1-PLD1 interaction may offer a strategy for inhibiting oncogene-driven cancer progression.